IP Library Granted Patent US 12,180,221
Granted Patent B2
US 12,180,221 · App. 17/028,778 · Granted Dec 31, 2024

Compounds and uses thereof

Inventors: Bertrand Le Bourdonnec (Northborough, MA); Matthew Lucas (Lexington, MA); Kerem Ozboya (Cambridge, MA); Bhaumik Pandya (Bedford, MA); Parcharee Tivitmahaisoon (Boston, MA); Iwona Wrona (Sharon, MA)
Assignee: JANSSEN PHARMACEUTICA NV
C07D491/107C07D213/82C07D237/04C07D237/24C07D401/12C07D401/14C07D403/12C07D405/14C07D409/14C07D413/12C07D417/12C07D417/14C07D471/04C07D487/04C07D495/04C07D513/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,180,221
App. No.
17/028,778
Granted
Dec 31, 2024
Kind
B2
Abstract

The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.

Claims (32)

1. A compound having the structure of Formula Ic:

wherein

R 1 is

wherein

each of R 3a , R 3b , R 3c , R 3d , and R 3e is, independently, H, F, Cl, Br, I, CN,

L 1 is optionally substituted C1-C6 alkylene; and

R 2 is

or a pharmaceutically acceptable salt thereof.

2. The compound of claim 1 , wherein L 1 is

3. The compound of claim 1 , wherein R 1 is

4. The compound of claim 1 , wherein R 1 is phenyl, 3-fluoro-phenyl, 4-fluoro-phenyl, 3-chloro-phenyl, 4-chloro-phenyl, 2-methoxy-phenyl, 3-methoxy-phenyl, 4-methoxy-phenyl, 3,4-di-fluoro-phenyl, 3,4-dichloro-phenyl, 3,5-di-fluoro-phenyl, 3,5-dichloro-phenyl, 3-chloro-4-fluoro-phenyl, 4-chloro-3-fluoro-phenyl, 3-chloro-4-nitrile-phenyl, 3-nitrile-4-fluoro-phenyl, 3 bromo-phenyl, 3 cyano-5-fluoro-phenyl, 3-chloro-5-fluoro-phenyl, 3-chloro-5-cyano-phenyl, or 3-chloro-5-methoxy-phenyl.

5. The compound of claim 1 , wherein the compound is selected from the group consisting of:

6. A pharmaceutical composition comprising a compound, or pharmaceutically acceptable salt thereof, of claim 1 , and a pharmaceutically acceptable excipient.

7. The compound of claim 1 , wherein the compound has the following structure:

or a pharmaceutically acceptable salt thereof.

8. The compound of claim 2 , wherein the compound is selected from the group consisting of:

9. The compound of claim 3 , wherein the compound is selected from the group consisting of:

10. The compound of claim 1 , wherein the compound is

11. The compound of claim 1 , wherein the compound is

12. The compound of claim 1 , wherein the compound is

or a pharmaceutically acceptable salt thereof.

13. The compound of claim 1 , wherein the compound is

or a pharmaceutically acceptable salt thereof.

14. The compound of claim 1 , wherein the compound is

or a pharmaceutically acceptable salt thereof.

15. The compound of claim 1 , wherein the compound is

or a pharmaceutically acceptable salt thereof.

16. The compound of claim 1 , wherein the compound is

17. The compound of claim 1 , wherein the compound is

18. The compound of claim 1 , wherein the compound is

19. The compound of claim 1 , wherein the compound is

20. The compound of claim 1 , wherein the compound is

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2022
From: YUMANITY THERAPEUTICS, INC.; YUMANITY, INC.
To: JANSSEN PHARMACEUTICA NV
Reel/Frame 062148/0414 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2021
From: BOURDONNEC, BERTRAND LE; LUCAS, MATTHEW; OZBOYA, KEREM; PANDYA, BHAUMIK; TARDIFF, DANIEL; TIVITMAHAISOON, PARCHAREE; WRONA, IWONA
To: YUMANITY THERAPEUTICS, INC.
Reel/Frame 057500/0162 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2021
From: LY, HUNG DINH
To: QUALCOMM INCORPORATED
Reel/Frame 055102/0306 →
Continuity (3)
Continuation PCTUS2019023737 · Mar 22, 2019
Provisional Application 62647308 · Mar 23, 2018
Related Publication 20220298168A1 · Sep 22, 2022